nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ALB—hematologic cancer	0.0978	1	CbGaD
Abiraterone—Testosterone—Prednisolone—hematologic cancer	0.0925	1	CrCrCtD
Abiraterone—ABCC1—Idarubicin—hematologic cancer	0.05	0.0978	CbGbCtD
Abiraterone—ABCC1—Daunorubicin—hematologic cancer	0.0354	0.0692	CbGbCtD
Abiraterone—CYP17A1—Dexamethasone—hematologic cancer	0.0326	0.0638	CbGbCtD
Abiraterone—ORM1—Imatinib—hematologic cancer	0.0297	0.0581	CbGbCtD
Abiraterone—ABCC1—Mitoxantrone—hematologic cancer	0.0215	0.042	CbGbCtD
Abiraterone—ABCC1—Epirubicin—hematologic cancer	0.0174	0.034	CbGbCtD
Abiraterone—ABCC1—Irinotecan—hematologic cancer	0.0169	0.0331	CbGbCtD
Abiraterone—CYP17A1—ovarian follicle—hematologic cancer	0.0168	0.348	CbGeAlD
Abiraterone—ABCC1—Vinblastine—hematologic cancer	0.015	0.0294	CbGbCtD
Abiraterone—ABCC1—Vincristine—hematologic cancer	0.0148	0.0289	CbGbCtD
Abiraterone—ABCC1—Etoposide—hematologic cancer	0.0135	0.0265	CbGbCtD
Abiraterone—CYP2C8—Bortezomib—hematologic cancer	0.0132	0.0258	CbGbCtD
Abiraterone—CYP2D6—Lomustine—hematologic cancer	0.0127	0.0249	CbGbCtD
Abiraterone—ALB—Imatinib—hematologic cancer	0.0125	0.0244	CbGbCtD
Abiraterone—CYP2D6—Idarubicin—hematologic cancer	0.0114	0.0222	CbGbCtD
Abiraterone—CYP2C8—Ifosfamide—hematologic cancer	0.0101	0.0198	CbGbCtD
Abiraterone—CYP2D6—Hydroxyurea—hematologic cancer	0.00966	0.0189	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—hematologic cancer	0.00924	0.0181	CbGbCtD
Abiraterone—ABCC1—Methotrexate—hematologic cancer	0.00895	0.0175	CbGbCtD
Abiraterone—CYP2C8—Nilotinib—hematologic cancer	0.00877	0.0172	CbGbCtD
Abiraterone—CYP3A4—Bexarotene—hematologic cancer	0.00872	0.0171	CbGbCtD
Abiraterone—CYP2D6—Bortezomib—hematologic cancer	0.0084	0.0164	CbGbCtD
Abiraterone—ALB—Prednisone—hematologic cancer	0.00823	0.0161	CbGbCtD
Abiraterone—CYP3A4—Lomustine—hematologic cancer	0.0081	0.0159	CbGbCtD
Abiraterone—CYP3A4—Busulfan—hematologic cancer	0.0081	0.0159	CbGbCtD
Abiraterone—ALB—Irinotecan—hematologic cancer	0.0078	0.0153	CbGbCtD
Abiraterone—CYP3A4—Thiotepa—hematologic cancer	0.00722	0.0141	CbGbCtD
Abiraterone—CYP2D6—Imatinib—hematologic cancer	0.00616	0.012	CbGbCtD
Abiraterone—CYP3A4—Methoxsalen—hematologic cancer	0.00562	0.011	CbGbCtD
Abiraterone—CYP2D6—Nilotinib—hematologic cancer	0.00559	0.0109	CbGbCtD
Abiraterone—CYP2D6—Vinorelbine—hematologic cancer	0.00555	0.0109	CbGbCtD
Abiraterone—CYP3A4—Bortezomib—hematologic cancer	0.00534	0.0105	CbGbCtD
Abiraterone—CYP3A4—Daunorubicin—hematologic cancer	0.00511	0.01	CbGbCtD
Abiraterone—CYP2C8—Etoposide—hematologic cancer	0.00483	0.00945	CbGbCtD
Abiraterone—SULT2A1—hematopoietic system—hematologic cancer	0.00465	0.0965	CbGeAlD
Abiraterone—CYP3A4—Cytarabine—hematologic cancer	0.00451	0.00882	CbGbCtD
Abiraterone—CYP3A4—Teniposide—hematologic cancer	0.00444	0.00869	CbGbCtD
Abiraterone—ALB—Methotrexate—hematologic cancer	0.00413	0.00808	CbGbCtD
Abiraterone—CYP3A4—Ifosfamide—hematologic cancer	0.0041	0.00802	CbGbCtD
Abiraterone—CYP2C8—Dexamethasone—hematologic cancer	0.00397	0.00777	CbGbCtD
Abiraterone—CYP3A4—Imatinib—hematologic cancer	0.00391	0.00766	CbGbCtD
Abiraterone—CYP3A4—Ruxolitinib—hematologic cancer	0.00369	0.00721	CbGbCtD
Abiraterone—CYP3A4—Nilotinib—hematologic cancer	0.00356	0.00696	CbGbCtD
Abiraterone—SULT2A1—gonad—hematologic cancer	0.00353	0.0734	CbGeAlD
Abiraterone—CYP3A4—Vinorelbine—hematologic cancer	0.00353	0.0069	CbGbCtD
Abiraterone—CYP2D6—Vinblastine—hematologic cancer	0.00342	0.00669	CbGbCtD
Abiraterone—CYP3A4—Triamcinolone—hematologic cancer	0.00323	0.00631	CbGbCtD
Abiraterone—CYP3A4—Dasatinib—hematologic cancer	0.00314	0.00615	CbGbCtD
Abiraterone—CYP3A4—Mitoxantrone—hematologic cancer	0.00311	0.00608	CbGbCtD
Abiraterone—SULT2A1—blood—hematologic cancer	0.00308	0.0639	CbGeAlD
Abiraterone—CYP3A4—Betamethasone—hematologic cancer	0.00277	0.00542	CbGbCtD
Abiraterone—CYP3A4—Prednisolone—hematologic cancer	0.00273	0.00534	CbGbCtD
Abiraterone—CYP3A4—Prednisone—hematologic cancer	0.00258	0.00505	CbGbCtD
Abiraterone—SULT2A1—testis—hematologic cancer	0.00255	0.0529	CbGeAlD
Abiraterone—CYP2D6—Dexamethasone—hematologic cancer	0.00253	0.00495	CbGbCtD
Abiraterone—CYP3A4—Irinotecan—hematologic cancer	0.00245	0.00478	CbGbCtD
Abiraterone—CYP3A4—Vinblastine—hematologic cancer	0.00217	0.00425	CbGbCtD
Abiraterone—CYP3A4—Vincristine—hematologic cancer	0.00214	0.00418	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—hematologic cancer	0.0021	0.00411	CbGbCtD
Abiraterone—CYP3A4—Etoposide—hematologic cancer	0.00196	0.00383	CbGbCtD
Abiraterone—SULT2A1—lymph node—hematologic cancer	0.00185	0.0383	CbGeAlD
Abiraterone—CYP3A4—Dexamethasone—hematologic cancer	0.00161	0.00315	CbGbCtD
Abiraterone—CYP17A1—gonad—hematologic cancer	0.00154	0.0319	CbGeAlD
Abiraterone—ORM1—hematopoietic system—hematologic cancer	0.00142	0.0295	CbGeAlD
Abiraterone—CYP3A4—Doxorubicin—hematologic cancer	0.00134	0.00261	CbGbCtD
Abiraterone—CYP17A1—testis—hematologic cancer	0.00111	0.023	CbGeAlD
Abiraterone—ORM1—blood—hematologic cancer	0.000941	0.0195	CbGeAlD
Abiraterone—ORM1—bone marrow—hematologic cancer	0.000911	0.0189	CbGeAlD
Abiraterone—CYP2C8—hematopoietic system—hematologic cancer	0.000875	0.0182	CbGeAlD
Abiraterone—ORM1—lung—hematologic cancer	0.000825	0.0171	CbGeAlD
Abiraterone—CYP17A1—lymph node—hematologic cancer	0.000803	0.0167	CbGeAlD
Abiraterone—ALB—testis—hematologic cancer	0.000683	0.0142	CbGeAlD
Abiraterone—ABCC1—blood—hematologic cancer	0.000681	0.0141	CbGeAlD
Abiraterone—ABCC1—lung—hematologic cancer	0.000597	0.0124	CbGeAlD
Abiraterone—CYP3A4—hematopoietic system—hematologic cancer	0.000593	0.0123	CbGeAlD
Abiraterone—CYP2D6—hematopoietic system—hematologic cancer	0.000583	0.0121	CbGeAlD
Abiraterone—CYP2C8—blood—hematologic cancer	0.00058	0.012	CbGeAlD
Abiraterone—ORM1—lymph node—hematologic cancer	0.000564	0.0117	CbGeAlD
Abiraterone—ABCC1—testis—hematologic cancer	0.000563	0.0117	CbGeAlD
Abiraterone—ALB—lymph node—hematologic cancer	0.000495	0.0103	CbGeAlD
Abiraterone—CYP2C8—testis—hematologic cancer	0.00048	0.00996	CbGeAlD
Abiraterone—ABCC1—lymph node—hematologic cancer	0.000408	0.00848	CbGeAlD
Abiraterone—CYP3A4—blood—hematologic cancer	0.000393	0.00816	CbGeAlD
Abiraterone—CYP2D6—blood—hematologic cancer	0.000387	0.00803	CbGeAlD
Abiraterone—Testosterone—SLC22A1—hematologic cancer	0.000346	0.314	CrCbGaD
Abiraterone—CYP2D6—testis—hematologic cancer	0.00032	0.00664	CbGeAlD
Abiraterone—Testosterone—AR—hematologic cancer	0.000307	0.279	CrCbGaD
Abiraterone—Testosterone—ABCG2—hematologic cancer	0.000241	0.219	CrCbGaD
Abiraterone—Testosterone—ALB—hematologic cancer	0.000105	0.0957	CrCbGaD
Abiraterone—Testosterone—ABCB1—hematologic cancer	0.0001	0.0913	CrCbGaD
Abiraterone—Vomiting—Bortezomib—hematologic cancer	5.02e-05	0.000272	CcSEcCtD
Abiraterone—Myalgia—Triamcinolone—hematologic cancer	5e-05	0.000271	CcSEcCtD
Abiraterone—Pneumonia—Methotrexate—hematologic cancer	4.99e-05	0.000271	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—hematologic cancer	4.99e-05	0.00027	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Cisplatin—hematologic cancer	4.98e-05	0.00027	CcSEcCtD
Abiraterone—Vomiting—Bleomycin—hematologic cancer	4.98e-05	0.00027	CcSEcCtD
Abiraterone—Rash—Bortezomib—hematologic cancer	4.97e-05	0.00027	CcSEcCtD
Abiraterone—Dermatitis—Bortezomib—hematologic cancer	4.97e-05	0.000269	CcSEcCtD
Abiraterone—Infestation NOS—Methotrexate—hematologic cancer	4.96e-05	0.000269	CcSEcCtD
Abiraterone—Infestation—Methotrexate—hematologic cancer	4.96e-05	0.000269	CcSEcCtD
Abiraterone—Discomfort—Triamcinolone—hematologic cancer	4.94e-05	0.000268	CcSEcCtD
Abiraterone—Rash—Bleomycin—hematologic cancer	4.94e-05	0.000268	CcSEcCtD
Abiraterone—Dermatitis—Bleomycin—hematologic cancer	4.93e-05	0.000267	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	4.92e-05	0.000267	CcSEcCtD
Abiraterone—Asthenia—Carmustine—hematologic cancer	4.9e-05	0.000266	CcSEcCtD
Abiraterone—Vomiting—Vinorelbine—hematologic cancer	4.9e-05	0.000265	CcSEcCtD
Abiraterone—Body temperature increased—Gemcitabine—hematologic cancer	4.89e-05	0.000265	CcSEcCtD
Abiraterone—Diarrhoea—Thalidomide—hematologic cancer	4.87e-05	0.000264	CcSEcCtD
Abiraterone—Asthenia—Alitretinoin—hematologic cancer	4.86e-05	0.000263	CcSEcCtD
Abiraterone—Rash—Vinorelbine—hematologic cancer	4.86e-05	0.000263	CcSEcCtD
Abiraterone—Dermatitis—Vinorelbine—hematologic cancer	4.85e-05	0.000263	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—hematologic cancer	4.84e-05	0.000262	CcSEcCtD
Abiraterone—Angiopathy—Prednisone—hematologic cancer	4.84e-05	0.000262	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—hematologic cancer	4.81e-05	0.000261	CcSEcCtD
Abiraterone—Asthenia—Ifosfamide—hematologic cancer	4.8e-05	0.00026	CcSEcCtD
Abiraterone—Oedema—Triamcinolone—hematologic cancer	4.79e-05	0.00026	CcSEcCtD
Abiraterone—Arrhythmia—Prednisone—hematologic cancer	4.76e-05	0.000258	CcSEcCtD
Abiraterone—Infection—Triamcinolone—hematologic cancer	4.76e-05	0.000258	CcSEcCtD
Abiraterone—Haematuria—Methotrexate—hematologic cancer	4.73e-05	0.000256	CcSEcCtD
Abiraterone—Insomnia—Prednisolone—hematologic cancer	4.71e-05	0.000255	CcSEcCtD
Abiraterone—Dyspnoea—Etoposide—hematologic cancer	4.71e-05	0.000255	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—hematologic cancer	4.7e-05	0.000255	CcSEcCtD
Abiraterone—Asthenia—Vincristine—hematologic cancer	4.68e-05	0.000254	CcSEcCtD
Abiraterone—Vomiting—Thiotepa—hematologic cancer	4.68e-05	0.000253	CcSEcCtD
Abiraterone—Diarrhoea—Carmustine—hematologic cancer	4.68e-05	0.000253	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—hematologic cancer	4.67e-05	0.000253	CcSEcCtD
Abiraterone—Mental disorder—Prednisone—hematologic cancer	4.67e-05	0.000253	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—hematologic cancer	4.64e-05	0.000252	CcSEcCtD
Abiraterone—Infestation—Epirubicin—hematologic cancer	4.64e-05	0.000252	CcSEcCtD
Abiraterone—Rash—Thiotepa—hematologic cancer	4.64e-05	0.000251	CcSEcCtD
Abiraterone—Dermatitis—Thiotepa—hematologic cancer	4.63e-05	0.000251	CcSEcCtD
Abiraterone—Diarrhoea—Alitretinoin—hematologic cancer	4.63e-05	0.000251	CcSEcCtD
Abiraterone—Hypertension—Betamethasone—hematologic cancer	4.6e-05	0.000249	CcSEcCtD
Abiraterone—Hypertension—Dexamethasone—hematologic cancer	4.6e-05	0.000249	CcSEcCtD
Abiraterone—Diarrhoea—Ifosfamide—hematologic cancer	4.58e-05	0.000248	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Etoposide—hematologic cancer	4.56e-05	0.000247	CcSEcCtD
Abiraterone—Body temperature increased—Cisplatin—hematologic cancer	4.56e-05	0.000247	CcSEcCtD
Abiraterone—Asthenia—Mitoxantrone—hematologic cancer	4.56e-05	0.000247	CcSEcCtD
Abiraterone—Asthenia—Irinotecan—hematologic cancer	4.56e-05	0.000247	CcSEcCtD
Abiraterone—Fatigue—Etoposide—hematologic cancer	4.56e-05	0.000247	CcSEcCtD
Abiraterone—Myalgia—Betamethasone—hematologic cancer	4.54e-05	0.000246	CcSEcCtD
Abiraterone—Myalgia—Dexamethasone—hematologic cancer	4.54e-05	0.000246	CcSEcCtD
Abiraterone—Vomiting—Thalidomide—hematologic cancer	4.52e-05	0.000245	CcSEcCtD
Abiraterone—Constipation—Etoposide—hematologic cancer	4.52e-05	0.000245	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—hematologic cancer	4.51e-05	0.000245	CcSEcCtD
Abiraterone—Rash—Thalidomide—hematologic cancer	4.49e-05	0.000243	CcSEcCtD
Abiraterone—Discomfort—Betamethasone—hematologic cancer	4.48e-05	0.000243	CcSEcCtD
Abiraterone—Discomfort—Dexamethasone—hematologic cancer	4.48e-05	0.000243	CcSEcCtD
Abiraterone—Dermatitis—Thalidomide—hematologic cancer	4.48e-05	0.000243	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—hematologic cancer	4.48e-05	0.000243	CcSEcCtD
Abiraterone—Diarrhoea—Vincristine—hematologic cancer	4.46e-05	0.000242	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—hematologic cancer	4.45e-05	0.000241	CcSEcCtD
Abiraterone—Asthenia—Gemcitabine—hematologic cancer	4.44e-05	0.000241	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—hematologic cancer	4.43e-05	0.00024	CcSEcCtD
Abiraterone—Urinary tract disorder—Methotrexate—hematologic cancer	4.4e-05	0.000238	CcSEcCtD
Abiraterone—Urethral disorder—Methotrexate—hematologic cancer	4.37e-05	0.000237	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	4.37e-05	0.000237	CcSEcCtD
Abiraterone—Oedema—Dexamethasone—hematologic cancer	4.35e-05	0.000236	CcSEcCtD
Abiraterone—Oedema—Betamethasone—hematologic cancer	4.35e-05	0.000236	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—hematologic cancer	4.35e-05	0.000236	CcSEcCtD
Abiraterone—Diarrhoea—Irinotecan—hematologic cancer	4.35e-05	0.000236	CcSEcCtD
Abiraterone—Diarrhoea—Mitoxantrone—hematologic cancer	4.35e-05	0.000236	CcSEcCtD
Abiraterone—Vomiting—Carmustine—hematologic cancer	4.35e-05	0.000235	CcSEcCtD
Abiraterone—Insomnia—Triamcinolone—hematologic cancer	4.34e-05	0.000235	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—hematologic cancer	4.32e-05	0.000234	CcSEcCtD
Abiraterone—Infection—Dexamethasone—hematologic cancer	4.32e-05	0.000234	CcSEcCtD
Abiraterone—Infection—Betamethasone—hematologic cancer	4.32e-05	0.000234	CcSEcCtD
Abiraterone—Rash—Carmustine—hematologic cancer	4.31e-05	0.000234	CcSEcCtD
Abiraterone—Dermatitis—Carmustine—hematologic cancer	4.31e-05	0.000233	CcSEcCtD
Abiraterone—Vomiting—Alitretinoin—hematologic cancer	4.3e-05	0.000233	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—hematologic cancer	4.3e-05	0.000233	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—hematologic cancer	4.3e-05	0.000233	CcSEcCtD
Abiraterone—Anaemia—Prednisone—hematologic cancer	4.29e-05	0.000232	CcSEcCtD
Abiraterone—Dyspnoea—Triamcinolone—hematologic cancer	4.27e-05	0.000232	CcSEcCtD
Abiraterone—Rash—Alitretinoin—hematologic cancer	4.27e-05	0.000231	CcSEcCtD
Abiraterone—Dermatitis—Alitretinoin—hematologic cancer	4.26e-05	0.000231	CcSEcCtD
Abiraterone—Vomiting—Ifosfamide—hematologic cancer	4.25e-05	0.000231	CcSEcCtD
Abiraterone—Diarrhoea—Gemcitabine—hematologic cancer	4.23e-05	0.000229	CcSEcCtD
Abiraterone—Dyspepsia—Triamcinolone—hematologic cancer	4.22e-05	0.000229	CcSEcCtD
Abiraterone—Rash—Ifosfamide—hematologic cancer	4.22e-05	0.000229	CcSEcCtD
Abiraterone—Dermatitis—Ifosfamide—hematologic cancer	4.22e-05	0.000228	CcSEcCtD
Abiraterone—Body temperature increased—Etoposide—hematologic cancer	4.18e-05	0.000226	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—hematologic cancer	4.18e-05	0.000226	CcSEcCtD
Abiraterone—Vomiting—Vincristine—hematologic cancer	4.15e-05	0.000225	CcSEcCtD
Abiraterone—Asthenia—Cisplatin—hematologic cancer	4.14e-05	0.000224	CcSEcCtD
Abiraterone—Cardiac disorder—Methotrexate—hematologic cancer	4.14e-05	0.000224	CcSEcCtD
Abiraterone—Fatigue—Triamcinolone—hematologic cancer	4.13e-05	0.000224	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—hematologic cancer	4.12e-05	0.000223	CcSEcCtD
Abiraterone—Rash—Vincristine—hematologic cancer	4.11e-05	0.000223	CcSEcCtD
Abiraterone—Dermatitis—Vincristine—hematologic cancer	4.11e-05	0.000223	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—hematologic cancer	4.1e-05	0.000222	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—hematologic cancer	4.1e-05	0.000222	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—hematologic cancer	4.09e-05	0.000221	CcSEcCtD
Abiraterone—Angiopathy—Methotrexate—hematologic cancer	4.04e-05	0.000219	CcSEcCtD
Abiraterone—Vomiting—Mitoxantrone—hematologic cancer	4.04e-05	0.000219	CcSEcCtD
Abiraterone—Vomiting—Irinotecan—hematologic cancer	4.04e-05	0.000219	CcSEcCtD
Abiraterone—Mediastinal disorder—Methotrexate—hematologic cancer	4.02e-05	0.000218	CcSEcCtD
Abiraterone—Hypertension—Prednisone—hematologic cancer	4.01e-05	0.000217	CcSEcCtD
Abiraterone—Rash—Irinotecan—hematologic cancer	4.01e-05	0.000217	CcSEcCtD
Abiraterone—Rash—Mitoxantrone—hematologic cancer	4.01e-05	0.000217	CcSEcCtD
Abiraterone—Dermatitis—Irinotecan—hematologic cancer	4e-05	0.000217	CcSEcCtD
Abiraterone—Dermatitis—Mitoxantrone—hematologic cancer	4e-05	0.000217	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.96e-05	0.000215	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.96e-05	0.000215	CcSEcCtD
Abiraterone—Myalgia—Prednisone—hematologic cancer	3.95e-05	0.000214	CcSEcCtD
Abiraterone—Diarrhoea—Cisplatin—hematologic cancer	3.95e-05	0.000214	CcSEcCtD
Abiraterone—Vomiting—Gemcitabine—hematologic cancer	3.93e-05	0.000213	CcSEcCtD
Abiraterone—Insomnia—Dexamethasone—hematologic cancer	3.93e-05	0.000213	CcSEcCtD
Abiraterone—Insomnia—Betamethasone—hematologic cancer	3.93e-05	0.000213	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.92e-05	0.000213	CcSEcCtD
Abiraterone—Discomfort—Prednisone—hematologic cancer	3.9e-05	0.000212	CcSEcCtD
Abiraterone—Mental disorder—Methotrexate—hematologic cancer	3.9e-05	0.000212	CcSEcCtD
Abiraterone—Rash—Gemcitabine—hematologic cancer	3.9e-05	0.000211	CcSEcCtD
Abiraterone—Dermatitis—Gemcitabine—hematologic cancer	3.9e-05	0.000211	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—hematologic cancer	3.87e-05	0.00021	CcSEcCtD
Abiraterone—Dyspepsia—Betamethasone—hematologic cancer	3.83e-05	0.000207	CcSEcCtD
Abiraterone—Dyspepsia—Dexamethasone—hematologic cancer	3.83e-05	0.000207	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—hematologic cancer	3.81e-05	0.000206	CcSEcCtD
Abiraterone—Asthenia—Etoposide—hematologic cancer	3.79e-05	0.000205	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—hematologic cancer	3.79e-05	0.000205	CcSEcCtD
Abiraterone—Body temperature increased—Triamcinolone—hematologic cancer	3.79e-05	0.000205	CcSEcCtD
Abiraterone—Oedema—Prednisone—hematologic cancer	3.79e-05	0.000205	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—hematologic cancer	3.78e-05	0.000205	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—hematologic cancer	3.78e-05	0.000205	CcSEcCtD
Abiraterone—Infection—Prednisone—hematologic cancer	3.76e-05	0.000204	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—hematologic cancer	3.76e-05	0.000204	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.75e-05	0.000203	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.75e-05	0.000203	CcSEcCtD
Abiraterone—Fatigue—Betamethasone—hematologic cancer	3.75e-05	0.000203	CcSEcCtD
Abiraterone—Fatigue—Dexamethasone—hematologic cancer	3.75e-05	0.000203	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—hematologic cancer	3.72e-05	0.000202	CcSEcCtD
Abiraterone—Skin disorder—Prednisone—hematologic cancer	3.68e-05	0.000199	CcSEcCtD
Abiraterone—Vomiting—Cisplatin—hematologic cancer	3.67e-05	0.000199	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—hematologic cancer	3.65e-05	0.000198	CcSEcCtD
Abiraterone—Rash—Cisplatin—hematologic cancer	3.64e-05	0.000197	CcSEcCtD
Abiraterone—Dermatitis—Cisplatin—hematologic cancer	3.63e-05	0.000197	CcSEcCtD
Abiraterone—Diarrhoea—Etoposide—hematologic cancer	3.62e-05	0.000196	CcSEcCtD
Abiraterone—Anaemia—Methotrexate—hematologic cancer	3.58e-05	0.000194	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—hematologic cancer	3.58e-05	0.000194	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—hematologic cancer	3.5e-05	0.00019	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—hematologic cancer	3.48e-05	0.000188	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.45e-05	0.000187	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—hematologic cancer	3.45e-05	0.000187	CcSEcCtD
Abiraterone—Asthenia—Triamcinolone—hematologic cancer	3.44e-05	0.000186	CcSEcCtD
Abiraterone—Body temperature increased—Betamethasone—hematologic cancer	3.44e-05	0.000186	CcSEcCtD
Abiraterone—Body temperature increased—Dexamethasone—hematologic cancer	3.44e-05	0.000186	CcSEcCtD
Abiraterone—Insomnia—Prednisone—hematologic cancer	3.43e-05	0.000186	CcSEcCtD
Abiraterone—Cough—Methotrexate—hematologic cancer	3.38e-05	0.000183	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—hematologic cancer	3.38e-05	0.000183	CcSEcCtD
Abiraterone—Vomiting—Etoposide—hematologic cancer	3.36e-05	0.000182	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—hematologic cancer	3.35e-05	0.000182	CcSEcCtD
Abiraterone—Dyspepsia—Prednisone—hematologic cancer	3.33e-05	0.000181	CcSEcCtD
Abiraterone—Rash—Etoposide—hematologic cancer	3.33e-05	0.000181	CcSEcCtD
Abiraterone—Dermatitis—Etoposide—hematologic cancer	3.33e-05	0.00018	CcSEcCtD
Abiraterone—Myalgia—Methotrexate—hematologic cancer	3.3e-05	0.000179	CcSEcCtD
Abiraterone—Chest pain—Methotrexate—hematologic cancer	3.3e-05	0.000179	CcSEcCtD
Abiraterone—Rash—Prednisolone—hematologic cancer	3.29e-05	0.000178	CcSEcCtD
Abiraterone—Dermatitis—Prednisolone—hematologic cancer	3.28e-05	0.000178	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.28e-05	0.000178	CcSEcCtD
Abiraterone—Fatigue—Prednisone—hematologic cancer	3.27e-05	0.000177	CcSEcCtD
Abiraterone—Discomfort—Methotrexate—hematologic cancer	3.26e-05	0.000177	CcSEcCtD
Abiraterone—Constipation—Prednisone—hematologic cancer	3.24e-05	0.000176	CcSEcCtD
Abiraterone—Cough—Epirubicin—hematologic cancer	3.17e-05	0.000172	CcSEcCtD
Abiraterone—Infection—Methotrexate—hematologic cancer	3.14e-05	0.00017	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—hematologic cancer	3.13e-05	0.00017	CcSEcCtD
Abiraterone—Asthenia—Dexamethasone—hematologic cancer	3.12e-05	0.000169	CcSEcCtD
Abiraterone—Asthenia—Betamethasone—hematologic cancer	3.12e-05	0.000169	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—hematologic cancer	3.1e-05	0.000168	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—hematologic cancer	3.09e-05	0.000167	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—hematologic cancer	3.09e-05	0.000167	CcSEcCtD
Abiraterone—Skin disorder—Methotrexate—hematologic cancer	3.07e-05	0.000167	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.07e-05	0.000166	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—hematologic cancer	3.05e-05	0.000165	CcSEcCtD
Abiraterone—Vomiting—Triamcinolone—hematologic cancer	3.05e-05	0.000165	CcSEcCtD
Abiraterone—Rash—Triamcinolone—hematologic cancer	3.02e-05	0.000164	CcSEcCtD
Abiraterone—Dermatitis—Triamcinolone—hematologic cancer	3.02e-05	0.000164	CcSEcCtD
Abiraterone—Body temperature increased—Prednisone—hematologic cancer	2.99e-05	0.000162	CcSEcCtD
Abiraterone—Diarrhoea—Dexamethasone—hematologic cancer	2.98e-05	0.000161	CcSEcCtD
Abiraterone—Diarrhoea—Betamethasone—hematologic cancer	2.98e-05	0.000161	CcSEcCtD
Abiraterone—Oedema—Epirubicin—hematologic cancer	2.96e-05	0.000161	CcSEcCtD
Abiraterone—Infection—Epirubicin—hematologic cancer	2.94e-05	0.000159	CcSEcCtD
Abiraterone—Cough—Doxorubicin—hematologic cancer	2.93e-05	0.000159	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—hematologic cancer	2.9e-05	0.000157	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.88e-05	0.000156	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—hematologic cancer	2.88e-05	0.000156	CcSEcCtD
Abiraterone—Insomnia—Methotrexate—hematologic cancer	2.86e-05	0.000155	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—hematologic cancer	2.86e-05	0.000155	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—hematologic cancer	2.86e-05	0.000155	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.84e-05	0.000154	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—hematologic cancer	2.83e-05	0.000153	CcSEcCtD
Abiraterone—Dyspnoea—Methotrexate—hematologic cancer	2.82e-05	0.000153	CcSEcCtD
Abiraterone—Dyspepsia—Methotrexate—hematologic cancer	2.79e-05	0.000151	CcSEcCtD
Abiraterone—Vomiting—Betamethasone—hematologic cancer	2.77e-05	0.00015	CcSEcCtD
Abiraterone—Vomiting—Dexamethasone—hematologic cancer	2.77e-05	0.00015	CcSEcCtD
Abiraterone—Rash—Dexamethasone—hematologic cancer	2.74e-05	0.000149	CcSEcCtD
Abiraterone—Rash—Betamethasone—hematologic cancer	2.74e-05	0.000149	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—hematologic cancer	2.74e-05	0.000149	CcSEcCtD
Abiraterone—Dermatitis—Dexamethasone—hematologic cancer	2.74e-05	0.000148	CcSEcCtD
Abiraterone—Dermatitis—Betamethasone—hematologic cancer	2.74e-05	0.000148	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.73e-05	0.000148	CcSEcCtD
Abiraterone—Fatigue—Methotrexate—hematologic cancer	2.73e-05	0.000148	CcSEcCtD
Abiraterone—Infection—Doxorubicin—hematologic cancer	2.72e-05	0.000148	CcSEcCtD
Abiraterone—Asthenia—Prednisone—hematologic cancer	2.72e-05	0.000147	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.7e-05	0.000146	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—hematologic cancer	2.68e-05	0.000145	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—hematologic cancer	2.66e-05	0.000144	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—hematologic cancer	2.64e-05	0.000143	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—hematologic cancer	2.61e-05	0.000141	CcSEcCtD
Abiraterone—Diarrhoea—Prednisone—hematologic cancer	2.59e-05	0.00014	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.56e-05	0.000139	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—hematologic cancer	2.55e-05	0.000138	CcSEcCtD
Abiraterone—Constipation—Epirubicin—hematologic cancer	2.53e-05	0.000137	CcSEcCtD
Abiraterone—Body temperature increased—Methotrexate—hematologic cancer	2.5e-05	0.000136	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.5e-05	0.000135	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—hematologic cancer	2.48e-05	0.000134	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—hematologic cancer	2.44e-05	0.000132	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—hematologic cancer	2.41e-05	0.000131	CcSEcCtD
Abiraterone—Vomiting—Prednisone—hematologic cancer	2.41e-05	0.000131	CcSEcCtD
Abiraterone—Rash—Prednisone—hematologic cancer	2.39e-05	0.000129	CcSEcCtD
Abiraterone—Dermatitis—Prednisone—hematologic cancer	2.39e-05	0.000129	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.37e-05	0.000128	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—hematologic cancer	2.36e-05	0.000128	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—hematologic cancer	2.34e-05	0.000127	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—hematologic cancer	2.34e-05	0.000127	CcSEcCtD
Abiraterone—Asthenia—Methotrexate—hematologic cancer	2.27e-05	0.000123	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—hematologic cancer	2.17e-05	0.000117	CcSEcCtD
Abiraterone—Diarrhoea—Methotrexate—hematologic cancer	2.17e-05	0.000117	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—hematologic cancer	2.13e-05	0.000115	CcSEcCtD
Abiraterone—Diarrhoea—Epirubicin—hematologic cancer	2.03e-05	0.00011	CcSEcCtD
Abiraterone—Vomiting—Methotrexate—hematologic cancer	2.01e-05	0.000109	CcSEcCtD
Abiraterone—Rash—Methotrexate—hematologic cancer	2e-05	0.000108	CcSEcCtD
Abiraterone—Dermatitis—Methotrexate—hematologic cancer	1.99e-05	0.000108	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—hematologic cancer	1.97e-05	0.000107	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—hematologic cancer	1.88e-05	0.000102	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—hematologic cancer	1.88e-05	0.000102	CcSEcCtD
Abiraterone—Rash—Epirubicin—hematologic cancer	1.87e-05	0.000101	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—hematologic cancer	1.87e-05	0.000101	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—hematologic cancer	1.74e-05	9.44e-05	CcSEcCtD
Abiraterone—Rash—Doxorubicin—hematologic cancer	1.73e-05	9.37e-05	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—hematologic cancer	1.73e-05	9.36e-05	CcSEcCtD
Abiraterone—ALB—Metabolism—UGT1A1—hematologic cancer	7.17e-06	0.000111	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ABCB1—hematologic cancer	7.14e-06	0.00011	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PDGFB—hematologic cancer	7.12e-06	0.00011	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3R1—hematologic cancer	7.08e-06	0.000109	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC22A1—hematologic cancer	7.01e-06	0.000108	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CRABP1—hematologic cancer	7.01e-06	0.000108	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC22A1—hematologic cancer	6.97e-06	0.000108	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CRABP1—hematologic cancer	6.97e-06	0.000108	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TSC2—hematologic cancer	6.96e-06	0.000107	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ARNTL—hematologic cancer	6.96e-06	0.000107	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NCOR1—hematologic cancer	6.93e-06	0.000107	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTM1—hematologic cancer	6.93e-06	0.000107	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CG—hematologic cancer	6.89e-06	0.000106	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CDA—hematologic cancer	6.87e-06	0.000106	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALOX5—hematologic cancer	6.83e-06	0.000105	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALOX5—hematologic cancer	6.79e-06	0.000105	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PTPN11—hematologic cancer	6.77e-06	0.000104	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CA9—hematologic cancer	6.77e-06	0.000104	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ACP5—hematologic cancer	6.77e-06	0.000104	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FGFR3—hematologic cancer	6.7e-06	0.000103	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOR2—hematologic cancer	6.68e-06	0.000103	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NUP98—hematologic cancer	6.62e-06	0.000102	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PC—hematologic cancer	6.61e-06	0.000102	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NUP98—hematologic cancer	6.58e-06	0.000101	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CB—hematologic cancer	6.54e-06	0.000101	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ADCY7—hematologic cancer	6.42e-06	9.91e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOA3—hematologic cancer	6.42e-06	9.91e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CREBBP—hematologic cancer	6.39e-06	9.86e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ADCY7—hematologic cancer	6.39e-06	9.85e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOA3—hematologic cancer	6.39e-06	9.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GBA—hematologic cancer	6.38e-06	9.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.38e-06	9.85e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NUP214—hematologic cancer	6.38e-06	9.84e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—IDH1—hematologic cancer	6.36e-06	9.82e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—BAD—hematologic cancer	6.35e-06	9.79e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NUP214—hematologic cancer	6.34e-06	9.78e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.31e-06	9.74e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCC3—hematologic cancer	6.29e-06	9.71e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TXN—hematologic cancer	6.29e-06	9.71e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTO1—hematologic cancer	6.29e-06	9.71e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOTCH1—hematologic cancer	6.29e-06	9.69e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.28e-06	9.68e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCG2—hematologic cancer	6.25e-06	9.64e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTR—hematologic cancer	6.25e-06	9.64e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.25e-06	9.64e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTR—hematologic cancer	6.21e-06	9.58e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCG2—hematologic cancer	6.21e-06	9.58e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SPHK1—hematologic cancer	6.16e-06	9.5e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD80—hematologic cancer	6.16e-06	9.5e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KIT—hematologic cancer	6.15e-06	9.48e-05	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—hematologic cancer	6.14e-06	9.47e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ENO2—hematologic cancer	6.13e-06	9.45e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—hematologic cancer	6.13e-06	9.45e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ENO2—hematologic cancer	6.09e-06	9.4e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CD—hematologic cancer	6.06e-06	9.35e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTPN11—hematologic cancer	6.04e-06	9.31e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTT1—hematologic cancer	5.94e-06	9.17e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.92e-06	9.13e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTT1—hematologic cancer	5.91e-06	9.11e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.85e-06	9.03e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CREB1—hematologic cancer	5.85e-06	9.02e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTAP—hematologic cancer	5.84e-06	9.01e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.82e-06	8.98e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SDC1—hematologic cancer	5.81e-06	8.96e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—BRAF—hematologic cancer	5.78e-06	8.91e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SDC1—hematologic cancer	5.78e-06	8.91e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.76e-06	8.88e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.76e-06	8.88e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3R1—hematologic cancer	5.72e-06	8.83e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6R—hematologic cancer	5.71e-06	8.8e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CREBBP—hematologic cancer	5.7e-06	8.79e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTEN—hematologic cancer	5.65e-06	8.72e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.61e-06	8.65e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—JAK2—hematologic cancer	5.56e-06	8.58e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.55e-06	8.56e-05	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.53e-06	8.53e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.52e-06	8.51e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.48e-06	8.45e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAP2K1—hematologic cancer	5.44e-06	8.39e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NUP98—hematologic cancer	5.43e-06	8.38e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CD—hematologic cancer	5.4e-06	8.33e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.4e-06	8.33e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—EP300—hematologic cancer	5.39e-06	8.31e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CB—hematologic cancer	5.28e-06	8.15e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ADCY7—hematologic cancer	5.27e-06	8.13e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA3—hematologic cancer	5.27e-06	8.13e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.24e-06	8.08e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NUP214—hematologic cancer	5.24e-06	8.08e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.21e-06	8.04e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FHL2—hematologic cancer	5.2e-06	8.03e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FGF2—hematologic cancer	5.17e-06	7.98e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CG—hematologic cancer	5.15e-06	7.94e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.13e-06	7.91e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTR—hematologic cancer	5.13e-06	7.91e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AGRN—hematologic cancer	5.1e-06	7.87e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.1e-06	7.87e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3R1—hematologic cancer	5.1e-06	7.87e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ENO2—hematologic cancer	5.03e-06	7.76e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—JAK2—hematologic cancer	4.96e-06	7.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NQO1—hematologic cancer	4.94e-06	7.62e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CD44—hematologic cancer	4.94e-06	7.62e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CD44—hematologic cancer	4.91e-06	7.58e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NQO1—hematologic cancer	4.91e-06	7.58e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.88e-06	7.53e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—hematologic cancer	4.85e-06	7.48e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MDM2—hematologic cancer	4.84e-06	7.47e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—IDH2—hematologic cancer	4.84e-06	7.46e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMMR—hematologic cancer	4.84e-06	7.46e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.84e-06	7.46e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.81e-06	7.42e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CREBBP—hematologic cancer	4.77e-06	7.36e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SDC1—hematologic cancer	4.77e-06	7.36e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CB—hematologic cancer	4.71e-06	7.26e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTOR—hematologic cancer	4.71e-06	7.26e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD4—hematologic cancer	4.7e-06	7.25e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYCS—hematologic cancer	4.67e-06	7.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYCS—hematologic cancer	4.65e-06	7.17e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.64e-06	7.16e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HSP90AA1—hematologic cancer	4.62e-06	7.12e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.55e-06	7.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CD—hematologic cancer	4.53e-06	6.98e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—hematologic cancer	4.47e-06	6.89e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA9—hematologic cancer	4.43e-06	6.83e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACP5—hematologic cancer	4.43e-06	6.83e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—hematologic cancer	4.42e-06	6.82e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.37e-06	6.74e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—EP300—hematologic cancer	4.35e-06	6.71e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3R1—hematologic cancer	4.27e-06	6.59e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SRC—hematologic cancer	4.23e-06	6.53e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.18e-06	6.45e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—IDH1—hematologic cancer	4.16e-06	6.42e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.16e-06	6.41e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—hematologic cancer	4.12e-06	6.36e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.12e-06	6.35e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TXN—hematologic cancer	4.11e-06	6.35e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.11e-06	6.35e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.11e-06	6.35e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—hematologic cancer	4.1e-06	6.32e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1A—hematologic cancer	4.08e-06	6.29e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NRAS—hematologic cancer	4.07e-06	6.28e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—hematologic cancer	4.07e-06	6.28e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CD44—hematologic cancer	4.06e-06	6.25e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NQO1—hematologic cancer	4.06e-06	6.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.03e-06	6.21e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—hematologic cancer	3.99e-06	6.15e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.99e-06	6.15e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.96e-06	6.11e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CB—hematologic cancer	3.94e-06	6.08e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK3—hematologic cancer	3.9e-06	6.02e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.9e-06	6.01e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EP300—hematologic cancer	3.88e-06	5.99e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCB1—hematologic cancer	3.88e-06	5.98e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.87e-06	5.97e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYCS—hematologic cancer	3.84e-06	5.92e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.81e-06	5.88e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.79e-06	5.84e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.79e-06	5.84e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—hematologic cancer	3.78e-06	5.84e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SRC—hematologic cancer	3.77e-06	5.82e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—hematologic cancer	3.76e-06	5.81e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOR1—hematologic cancer	3.76e-06	5.81e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.76e-06	5.8e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.76e-06	5.8e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.67e-06	5.66e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—hematologic cancer	3.64e-06	5.61e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NRAS—hematologic cancer	3.63e-06	5.6e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NUP98—hematologic cancer	3.55e-06	5.48e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—hematologic cancer	3.51e-06	5.41e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK3—hematologic cancer	3.48e-06	5.36e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.45e-06	5.32e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.45e-06	5.32e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NUP214—hematologic cancer	3.42e-06	5.28e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—hematologic cancer	3.41e-06	5.26e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—hematologic cancer	3.38e-06	5.22e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.38e-06	5.22e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—hematologic cancer	3.37e-06	5.2e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.35e-06	5.17e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTR—hematologic cancer	3.35e-06	5.17e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.35e-06	5.16e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—hematologic cancer	3.33e-06	5.13e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ENO2—hematologic cancer	3.29e-06	5.07e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—hematologic cancer	3.26e-06	5.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—EP300—hematologic cancer	3.25e-06	5.01e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—hematologic cancer	3.22e-06	4.97e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.2e-06	4.94e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.19e-06	4.92e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—hematologic cancer	3.13e-06	4.82e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SDC1—hematologic cancer	3.12e-06	4.81e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—hematologic cancer	3.12e-06	4.8e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.11e-06	4.79e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.11e-06	4.79e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—hematologic cancer	2.98e-06	4.6e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.95e-06	4.55e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.93e-06	4.52e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—hematologic cancer	2.87e-06	4.43e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.81e-06	4.34e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CG—hematologic cancer	2.8e-06	4.31e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.75e-06	4.24e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—hematologic cancer	2.66e-06	4.1e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.65e-06	4.09e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CD44—hematologic cancer	2.65e-06	4.09e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—hematologic cancer	2.63e-06	4.06e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.61e-06	4.02e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CREBBP—hematologic cancer	2.59e-06	4e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—hematologic cancer	2.54e-06	3.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.51e-06	3.87e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.49e-06	3.84e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.47e-06	3.81e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CD—hematologic cancer	2.46e-06	3.79e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—hematologic cancer	2.44e-06	3.76e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—hematologic cancer	2.4e-06	3.71e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—hematologic cancer	2.35e-06	3.62e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.33e-06	3.6e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3R1—hematologic cancer	2.32e-06	3.58e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.31e-06	3.56e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.21e-06	3.41e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.15e-06	3.32e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CB—hematologic cancer	2.14e-06	3.3e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.14e-06	3.3e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.09e-06	3.23e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.03e-06	3.13e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.03e-06	3.13e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.03e-06	3.13e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—hematologic cancer	2e-06	3.09e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—hematologic cancer	1.96e-06	3.03e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.92e-06	2.95e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.86e-06	2.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—hematologic cancer	1.85e-06	2.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.8e-06	2.77e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—EP300—hematologic cancer	1.78e-06	2.74e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.77e-06	2.73e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—EP300—hematologic cancer	1.76e-06	2.72e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.53e-06	2.36e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.51e-06	2.33e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—EP300—hematologic cancer	1.46e-06	2.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.4e-06	2.16e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.33e-06	2.05e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.31e-06	2.03e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—hematologic cancer	1.31e-06	2.02e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—hematologic cancer	1.31e-06	2.01e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.25e-06	1.93e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.16e-06	1.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.08e-06	1.66e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—hematologic cancer	1.07e-06	1.65e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—hematologic cancer	1.07e-06	1.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—hematologic cancer	9.99e-07	1.54e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—EP300—hematologic cancer	9.53e-07	1.47e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—hematologic cancer	8.81e-07	1.36e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.05e-07	1.09e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—hematologic cancer	5.76e-07	8.88e-06	CbGpPWpGaD
